Section Arrow
Quote
AMPH.NASDAQ
- Amphastar Pharmaceuticals
Quotes are at least 15-min delayed:2025/12/26 13:43 EST
Regular Hours
Last
 26.93
+0.12 (+0.45%)
Day High 
27.05 
Prev. Close
26.81 
1-M High
27.8388 
Volume 
81.27K 
Bid
26.87
Ask
26.92
Day Low
26.5536 
Open
26.77 
1-M Low
25.16 
Market Cap 
1.23B 
Currency 美元 
P/E 11.86 
%Yield -- 
10-SMA 26.28 
20-SMA 26.54 
50-SMA 25.72 
52-W High 39.01 
52-W Low 20.385 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.26/--
Enterprise Value
1.88B
Balance Sheet
Book Value Per Share
16.90
Cash Flow
Cash Flow Yield
0.12
Income Statement
Total Revenue
731.97M
Operating Revenue Per Share
13.09
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CGCCanopy Growth Corp1.2275-0.0825-6.30%-- 
HIMSHims & Hers Health34.3675-0.3025-0.87%65.13PE
IXHLIncannex Healthcare0.399199-0.011401-2.78%-- 
TLRYTilray Brands Inc.9.635-0.515-5.07%-- 
UPCUniverse Pharmaceuticals Inc5.02+0.735+17.15%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulinactive pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.